A. L. GLASEBROOK

Statistics

Publications

Citations

217

H-Index

Active since

1995

Affiliations

Eli Lilly (United States)(Current)

A. L. GLASEBROOK is an author at Eli Lilly (United States) specializing in medicine, pharmacodynamics, and parathyroid hormone effects on osteoclasts.

Publications per year

1995–2000

Publications

In Vivo Demonstration that Human Parathyroid Hormone 1–38 Inhibits the Expression of Osteoprotegerin in Bone with the Kinetics of an Immediate Early Gene

J.E. Onyia, Rebecca R. Miles, Xiaonan Yang et al. · Journal of Bone and Mineral Research · 2000 · 130 citations

Medicine, Cell Biology, Molecular Biology +15

Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor

Robin Fuchs‐Young, A. L. GLASEBROOK, Lorri L. Short et al. · Annals of the New York Academy of Sciences · 1995 · 87 citations

Medicine, Endocrinology, Pharmacology +12

1–2 of 2